Syndax Pharmaceuticals (SNDX) Revenue (2015 - 2026)
Syndax Pharmaceuticals (SNDX) posted quarterly Revenue of $64.9 million for Q1 2026, up 223.64% year-over-year from $20.0 million in Q1 2025, and down 5.62% quarter-over-quarter from $68.7 million in Q4 2025.
Syndax Pharmaceuticals (SNDX) Revenue (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Revenue history runs 10 years deep, the most recent figure standing at $64.9 million for Q1 2026.
- In Q1 2026, Revenue rose 223.64% year-over-year to $64.9 million; the TTM figure through Mar 2026 stood at $217.4 million (up 397.28% YoY), while the FY2025 annual figure was $172.4 million, up 627.84% from the prior year.
- Revenue for Q1 2026 stood at $64.9 million, down from $68.7 million in the prior quarter.
- The five-year high for Revenue was $68.7 million in Q4 2025, with the low at $3.5 million in Q2 2024.
- The 3-year median for Revenue is $29.0 million (2025), against an average of $32.6 million.
- The sharpest annual moves came in 2025 and 2026: Revenue soared 984.51% in 2025, then soared 223.64% in 2026.
- Syndax Pharmaceuticals' Revenue stood at $7.7 million in 2024, then surged by 794.9% to $68.7 million in 2025, then slipped by 5.62% to $64.9 million in 2026.
- Business Quant data shows SNDX's Revenue at $64.9 million in Q1 2026, $68.7 million in Q4 2025, and $45.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Syndax Pharmaceuticals | 1.77 Bn | 1.22 Bn | 60.67 Mn | 72.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72.79 Mn |
| Mar 31, 2026 | 64.86 Mn |
| Dec 31, 2025 | 68.73 Mn |
| Sep 30, 2025 | 45.87 Mn |
| Jun 30, 2025 | 37.96 Mn |
| Mar 31, 2025 | 20.04 Mn |
| Dec 31, 2024 | 7.68 Mn |
| Sep 30, 2024 | 12.50 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Dec 31, 2021 | 126.58 Mn |
| Sep 30, 2021 | 12.38 Mn |
| Jun 30, 2021 | 379,000.00 |
| Mar 31, 2021 | 379,000.00 |
| Dec 31, 2020 | 380,000.00 |
| Sep 30, 2020 | 379,000.00 |
| Jun 30, 2020 | 379,000.00 |
| Mar 31, 2020 | 379,000.00 |
| Dec 31, 2019 | 380,000.00 |
| Sep 30, 2019 | 379,000.00 |
| Jun 30, 2019 | 379,000.00 |